87 related articles for article (PubMed ID: 27140073)
1. Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy.
Feibus AH; Sartor O; Moparty K; Chagin K; Kattan MW; Ledet E; Levy J; Lee B; Thomas R; Silberstein JL
J Urol; 2016 Oct; 196(4):1053-60. PubMed ID: 27140073
[TBL] [Abstract][Full Text] [Related]
2. Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
Wei JT; Feng Z; Partin AW; Brown E; Thompson I; Sokoll L; Chan DW; Lotan Y; Kibel AS; Busby JE; Bidair M; Lin DW; Taneja SS; Viterbo R; Joon AY; Dahlgren J; Kagan J; Srivastava S; Sanda MG
J Clin Oncol; 2014 Dec; 32(36):4066-72. PubMed ID: 25385735
[TBL] [Abstract][Full Text] [Related]
3. Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer.
Loeb S; Lilja H; Vickers A
Curr Opin Urol; 2016 Sep; 26(5):459-65. PubMed ID: 27262138
[TBL] [Abstract][Full Text] [Related]
4. Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer.
Woo J; Santasusagna S; Banks J; Pastor-Lopez S; Yadav K; Carceles-Cordon M; Dominguez-Andres A; Den RB; Languino LR; Pippa R; Lallas CD; Lu-Yao G; Kelly WK; Knudsen KE; Rodriguez-Bravo V; Tewari AK; Prats JM; Leiby BE; Gomella LG; Domingo-Domenech J
J Urol; 2020 Oct; 204(4):691-700. PubMed ID: 32250729
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia.
Huang J; Reilly KH; Zhang HZ; Wang HB
BMC Urol; 2015 Dec; 15():118. PubMed ID: 26628213
[TBL] [Abstract][Full Text] [Related]
6. MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.
Tosoian JJ; Sessine MS; Trock BJ; Ross AE; Xie C; Zheng Y; Samora NL; Siddiqui J; Niknafs Y; Chopra Z; Tomlins S; Kunju LP; Palapattu GS; Morgan TM; Wei JT; Salami SS; Chinnaiyan AM
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):563-567. PubMed ID: 36585434
[TBL] [Abstract][Full Text] [Related]
7. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.
Yamoah K; Johnson MH; Choeurng V; Faisal FA; Yousefi K; Haddad Z; Ross AE; Alshalafa M; Den R; Lal P; Feldman M; Dicker AP; Klein EA; Davicioni E; Rebbeck TR; Schaeffer EM
J Clin Oncol; 2015 Sep; 33(25):2789-96. PubMed ID: 26195723
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer.
Hsing AW; Yeboah E; Biritwum R; Tettey Y; De Marzo AM; Adjei A; Netto GJ; Yu K; Li Y; Chokkalingam AP; Chu LW; Chia D; Partin A; Thompson IM; Quraishi SM; Niwa S; Tarone R; Hoover RN
J Urol; 2014 Sep; 192(3):730-5. PubMed ID: 24747091
[TBL] [Abstract][Full Text] [Related]
9. Urinary markers aiding in the detection and risk stratification of prostate cancer.
Raja N; Russell CM; George AK
Transl Androl Urol; 2018 Sep; 7(Suppl 4):S436-S442. PubMed ID: 30363496
[TBL] [Abstract][Full Text] [Related]
10. Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.
Kaur HB; Guedes LB; Lu J; Maldonado L; Reitz L; Barber JR; De Marzo AM; Tosoian JJ; Tomlins SA; Schaeffer EM; Joshu CE; Sfanos KS; Lotan TL
Mod Pathol; 2018 Oct; 31(10):1539-1552. PubMed ID: 29849114
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study.
Dutta A; Uno H; Holman A; Lorenz DR; Gabuzda D
Cancer Causes Control; 2017 Jul; 28(7):767-777. PubMed ID: 28451806
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing web-based decision aids on prostate cancer knowledge for African-American men.
Ellison GL; Weinrich SP; Lou M; Xu H; Powell IJ; Baquet CR
J Natl Med Assoc; 2008 Oct; 100(10):1139-45. PubMed ID: 18942274
[TBL] [Abstract][Full Text] [Related]
13. The Use of Biomarkers in Prostate Cancer Screening and Treatment.
Alford AV; Brito JM; Yadav KK; Yadav SS; Tewari AK; Renzulli J
Rev Urol; 2017; 19(4):221-234. PubMed ID: 29472826
[TBL] [Abstract][Full Text] [Related]
14. Lack of comprehension of common prostate cancer terms in an underserved population.
Kilbridge KL; Fraser G; Krahn M; Nelson EM; Conaway M; Bashore R; Wolf A; Barry MJ; Gong DA; Nease RF; Connors AF
J Clin Oncol; 2009 Apr; 27(12):2015-21. PubMed ID: 19307512
[TBL] [Abstract][Full Text] [Related]
15. Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial.
Murphy AB; Abern MR; Liu L; Wang H; Hollowell CMP; Sharifi R; Vidal P; Kajdacsy-Balla A; Sekosan M; Ferrer K; Wu S; Gallegos M; King-Lee P; Sharp LK; Ferrans CE; Gann PH
J Clin Oncol; 2021 May; 39(15):1660-1670. PubMed ID: 33835822
[TBL] [Abstract][Full Text] [Related]
16. A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential.
Batra JS; Girdhani S; Hlatky L
J Biomark; 2014; 2014():321680. PubMed ID: 26317031
[TBL] [Abstract][Full Text] [Related]
17. Applications of Urinary Extracellular Vesicles in the Diagnosis and Active Surveillance of Prostate Cancer.
Smith SF; Brewer DS; Hurst R; Cooper CS
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730670
[TBL] [Abstract][Full Text] [Related]
18. Best of the 2013 AUA Annual Meeting: Highlights From the 2013 American Urological Association Meeting, May 4-8, 2013, San Diego, CA.
Loeb S; Assimos D; Chancellor MB; Nickel JC; Brawer MK; Kern AJ; Partin AW
Rev Urol; 2013; 15(2):72-81. PubMed ID: 24082846
[No Abstract] [Full Text] [Related]
19. Empowering Communities: Fostering Prostate Cancer Awareness and Resilience Among Men of Color.
Trinh QD; Labban M; Daniels D; Feldman A
J Urol; 2024 May; ():101097JU0000000000003931. PubMed ID: 38703127
[No Abstract] [Full Text] [Related]
20. PCA3 Urinary Biomarker for Prostate Cancer.
Loeb S; Partin AW
Rev Urol; 2010; 12(4):e205-6. PubMed ID: 21234266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
